Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
17.56
-0.39 (-2.17%)
At close: Dec 5, 2025, 4:00 PM EST
17.22
-0.34 (-1.94%)
After-hours: Dec 5, 2025, 6:20 PM EST
Avalo Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -99.88 | -35.13 | -31.54 | -41.66 | -84.38 | -63.5 | Upgrade
|
| Depreciation & Amortization | 0.4 | 0.17 | 0.16 | 0.17 | 1.66 | 1.84 | Upgrade
|
| Other Amortization | - | - | 1.83 | 1.39 | 0.79 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 27.64 | 3.91 | - | - | 25.55 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.49 | - | - | - | - | -5.21 | Upgrade
|
| Stock-Based Compensation | 12.02 | 5.85 | 3.48 | 7.55 | 8.17 | 6.79 | Upgrade
|
| Other Operating Activities | 32.65 | -42.88 | 0.73 | 5.86 | 0.02 | -1.57 | Upgrade
|
| Change in Accounts Receivable | - | - | - | 1.06 | 1.12 | -0.68 | Upgrade
|
| Change in Inventory | - | - | 0.02 | 0.02 | -0.04 | 0.02 | Upgrade
|
| Change in Accounts Payable | -1.34 | -0.16 | -2.44 | -0.49 | 0.8 | 0.1 | Upgrade
|
| Change in Unearned Revenue | - | - | -0.09 | 0.09 | - | - | Upgrade
|
| Change in Income Taxes | - | - | - | - | - | 0.29 | Upgrade
|
| Change in Other Net Operating Assets | 4.39 | -4.55 | -6.74 | -0.74 | 0.96 | -4.16 | Upgrade
|
| Operating Cash Flow | -52.26 | -49.06 | -30.68 | -26.75 | -70.89 | -40.54 | Upgrade
|
| Capital Expenditures | - | - | -0.16 | -0.1 | -0.11 | -0.06 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.03 | - | - | - | Upgrade
|
| Cash Acquisitions | - | 0.36 | - | - | - | -1.64 | Upgrade
|
| Investment in Securities | -84.12 | - | - | - | - | 12.84 | Upgrade
|
| Investing Cash Flow | -84.12 | 0.36 | -0.13 | -0.1 | -0.11 | 11.13 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 32.9 | - | Upgrade
|
| Total Debt Issued | - | - | - | - | 32.9 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | -21.24 | -14.81 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -21.24 | -14.81 | 32.9 | - | Upgrade
|
| Issuance of Common Stock | 83.85 | 185.07 | 46.29 | 0.11 | 73.86 | 44.88 | Upgrade
|
| Repurchase of Common Stock | -0.51 | - | - | - | - | -0.09 | Upgrade
|
| Other Financing Activities | -1.73 | -9.22 | - | - | - | - | Upgrade
|
| Financing Cash Flow | 81.61 | 175.85 | 25.04 | -14.7 | 106.76 | 44.78 | Upgrade
|
| Net Cash Flow | -54.77 | 127.15 | -5.77 | -41.55 | 35.76 | 15.38 | Upgrade
|
| Free Cash Flow | -52.26 | -49.06 | -30.84 | -26.85 | -71.01 | -40.6 | Upgrade
|
| Free Cash Flow Margin | -27216.67% | -11123.81% | -1602.81% | -148.72% | -1315.39% | -606.09% | Upgrade
|
| Free Cash Flow Per Share | -4.58 | -6.54 | -111.04 | -684.81 | -1961.95 | -1591.55 | Upgrade
|
| Cash Interest Paid | - | - | 1.93 | 2.93 | 1.59 | - | Upgrade
|
| Cash Income Tax Paid | - | - | - | - | - | 0.47 | Upgrade
|
| Levered Free Cash Flow | -84.17 | -25.08 | -24.09 | -12.04 | -37.89 | -11.17 | Upgrade
|
| Unlevered Free Cash Flow | -84.17 | -25.08 | -23.78 | -10.82 | -37.19 | -11.17 | Upgrade
|
| Change in Working Capital | 3.05 | -4.71 | -9.24 | -0.06 | 2.84 | -4.44 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.